Product Information
RISEDRONATE SODIUM 35 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.3991 per EA under NDC 00093309844. Its NADAC has been published 558 times since Oct 21, 2015.
Strength
35 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093309844
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RISEDRONATE SODIUM MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA077132On Market Since
6/1/2015
Pharmacological Classes
Price Statistics
The NADAC for RISEDRONATE SODIUM 35 MG TAB has been published 558 times since Oct 21, 2015, and over the history we have for it it has declined 94.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3991 per EA |
|---|---|
| All-time high | $43.3459 (Feb 10, 2016) |
| All-time low | $1.1853 (Sep 20, 2023) |
| 52-week high | $2.4340 |
| 52-week low | $1.8164 |
| Median price | $4.2517 |
| Average price | $6.7854 |
| Largest weekly change | +76.8% (Dec 20, 2023) |
| Weeks tracked | 558 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RISEDRONATE SODIUM 35 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for RISEDRONATE SODIUM 35 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $2.3991 per EA (NDC 00093309844), effective Jun 24, 2026.
How has the price of RISEDRONATE SODIUM 35 MG TAB changed over time?
Over the history we have for it, the NADAC for RISEDRONATE SODIUM 35 MG TAB has declined 94.4%. It has been tracked across 558 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for RISEDRONATE SODIUM 35 MG TAB?
Since Oct 21, 2015, the NADAC for RISEDRONATE SODIUM 35 MG TAB has ranged from a low of $1.1853 (Sep 20, 2023) to a high of $43.3459 (Feb 10, 2016), with a median of $4.2517 per EA.
Are there cheaper alternatives to RISEDRONATE SODIUM 35 MG TAB?
4 NADAC-published products share the same active ingredient, strength, and dosage form as RISEDRONATE SODIUM 35 MG TAB, but none are currently priced below it.
Who manufactures RISEDRONATE SODIUM 35 MG TAB?
RISEDRONATE SODIUM 35 MG TAB (NDC 00093309844) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification